tiprankstipranks
Trending News
More News >
Sundaram Multi Pap Limited (IN:SUNDARAM)
:SUNDARAM
India Market

Sundaram Multi Pap Limited (SUNDARAM) AI Stock Analysis

Compare
0 Followers

Top Page

IN:SUNDARAM

Sundaram Multi Pap Limited

(SUNDARAM)

Select Model
Select Model
Select Model
Neutral 55 (OpenAI - 5.2)
,
Neutral 55 (OpenAI - 5.2)
,
Neutral 55 (OpenAI - 5.2)
,
Neutral 55 (OpenAI - 5.2)
,
Neutral 55 (OpenAI - 5.2)
,
Neutral 55 (OpenAI - 5.2)
,
Neutral 55 (OpenAI - 5.2)
,
Neutral 55 (OpenAI - 5.2)
,
Neutral 55 (OpenAI - 5.2)
,
Neutral 55 (OpenAI - 5.2)
,
Neutral 55 (OpenAI - 5.2)
,
Neutral 55 (OpenAI - 5.2)
Rating:55Neutral
Price Target:
₹1.50
▼(-16.20% Downside)
Action:ReiteratedDate:03/20/26
The score is primarily supported by a stable balance sheet and positive cash flow, but is materially constrained by negative profitability and a clear bearish technical setup (below major moving averages with negative MACD). Valuation is moderate and does not materially offset the fundamental and momentum concerns.
Positive Factors
Balance-sheet strength
A 72% equity ratio signals durable financial stability and a low reliance on creditors. This provides capacity to withstand cyclical downturns, fund capex or working capital from internal resources, and reduces refinancing risk over the next several quarters.
Positive cash generation
Rising operating cash flow and positive free cash flow indicate the core business converts revenue to cash effectively. That cash buffer supports operations, deleveraging or targeted reinvestment even while accounting profits are negative, preserving optionality.
Improving gross margins
An improving gross margin to 26.63% suggests better cost control or pricing power at the production level. Sustained gross margin improvements can support operating leverage once SG&A is managed, aiding durable profit recovery over months.
Negative Factors
Negative profitability
Negative EBIT and net income indicate the business currently fails to cover operating costs on an accounting basis. If sustained, this erodes retained earnings, constrains reinvestment and may force cost cuts or strategic shifts to restore long-term profitability.
Modest revenue growth
Very low top-line growth limits scope for scaling fixed-cost absorption and margin recovery. Without meaningful revenue expansion over the coming quarters, operational improvements may not translate into consistent profitable results or stronger market positioning.
Moderate leverage risk
A 0.31 debt/equity ratio is moderate but, combined with recurring losses, raises refinancing and interest coverage risk. If earnings remain negative, leverage could limit strategic flexibility and increase vulnerability to rate shocks over the medium term.

Sundaram Multi Pap Limited (SUNDARAM) vs. iShares MSCI India ETF (INDA)

Sundaram Multi Pap Limited Business Overview & Revenue Model

Company DescriptionSundaram Multi Pap Limited designs, manufactures, and markets paper stationery products for students in India. It offers exercise note, long, scrap, drawing, graph, A4/A5/A3, college, hard bound, sketch, lekhan, practical, laboratory, pocket, six subject, answer, duplicate, cash memo, challan, and voucher books. The company also provides conference pads; graph and map, answer, origami paper, and tinted sheets; office/corporate stationery products; and printing, writing, and packaging papers. In addition, it offers digital educational content for the students of Maharashtra State Board's 1st to 10th standards for various subjects available in English, Marathi, Semi English, Hindi, and Urdu medium as per the syllabus. The company markets and sells its products primarily under the Sundaram brand. It also exports its products. Sundaram Multi Pap Limited was incorporated in 1985 and is based in Mumbai, India.
How the Company Makes Moneynull

Sundaram Multi Pap Limited Financial Statement Overview

Summary
Balance sheet strength (72% equity ratio) and improving/positive operating and free cash flow support stability, but overall performance is held back by declining profitability with negative EBIT and net income and only modest revenue growth (+0.29%).
Income Statement
55
Neutral
The company shows a declining trend in profitability, with a negative EBIT and net income in the latest year. Gross profit margin has improved to 26.63%, but net profit margin remains negative at -4.02%. Revenue growth is modest with a 0.29% increase from the previous year, indicating challenges in revenue expansion.
Balance Sheet
62
Positive
The company maintains a strong equity position with an equity ratio of 72.00%, suggesting financial stability. However, the debt-to-equity ratio of 0.31 indicates moderate leverage, which could be a concern if profitability does not improve.
Cash Flow
68
Positive
Operating cash flow has increased, reflecting better cash management. The free cash flow to net income ratio is not calculable due to negative net income, but free cash flow remains positive, indicating adequate liquidity.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue1.28B1.27B1.27B1.14B703.58M505.92M
Gross Profit293.21M339.35M209.04M284.71M235.39M101.16M
EBITDA32.64M18.91M27.23M103.34M132.61M9.98M
Net Income-31.52M-51.21M-50.82M25.89M39.11M-88.35M
Balance Sheet
Total Assets1.00B1.22B1.35B1.38B1.46B1.48B
Cash, Cash Equivalents and Short-Term Investments168.07M211.03M2.23M26.04M3.63M4.47M
Total Debt211.52M268.68M333.90M346.19M393.68M446.90M
Total Liabilities319.38M340.64M419.45M403.71M510.26M567.60M
Stockholders Equity684.88M875.38M926.31M977.03M949.81M909.22M
Cash Flow
Free Cash Flow-66.30M68.89M34.87M108.36M49.50M52.54M
Operating Cash Flow-66.30M68.89M54.07M113.52M54.06M55.90M
Investing Cash Flow9.13M161.21M-19.35M-5.78M-3.18M19.99M
Financing Cash Flow-62.17M-90.21M-57.84M-86.03M-50.97M-80.95M

Sundaram Multi Pap Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.79
Price Trends
50DMA
1.56
Negative
100DMA
1.69
Negative
200DMA
1.87
Negative
Market Momentum
MACD
-0.10
Positive
RSI
27.74
Positive
STOCH
22.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SUNDARAM, the sentiment is Negative. The current price of 1.79 is above the 20-day moving average (MA) of 1.39, above the 50-day MA of 1.56, and below the 200-day MA of 1.87, indicating a bearish trend. The MACD of -0.10 indicates Positive momentum. The RSI at 27.74 is Positive, neither overbought nor oversold. The STOCH value of 22.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:SUNDARAM.

Sundaram Multi Pap Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
57
Neutral
₹751.10M10.21
55
Neutral
₹573.39M13.24-0.92%9.65%
49
Neutral
₹506.49M106.63
37
Underperform
₹678.99M-0.7711.54%34.32%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:SUNDARAM
Sundaram Multi Pap Limited
1.21
-0.88
-42.11%
IN:FCONSUMER
Future Consumer Limited
0.34
-0.18
-34.62%
IN:KLRF
Kovilpatti Lakshmi Roller Flour Mills Ltd
100.95
-0.62
-0.61%
IN:MHHL
Mohini Health & Hygiene Ltd.
39.00
-36.20
-48.14%
IN:PRITI
Priti International Ltd.
37.93
-58.29
-60.58%
IN:SPLIL
SPL Industries Limited
25.90
-13.00
-33.42%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 20, 2026